Showing posts with label epilepsy. Show all posts
Showing posts with label epilepsy. Show all posts

Thursday, January 27, 2022

Covid-19 can cause psychological problems; UK case is an example, and also of surgery that can prevent epileptic seizures

From left: Sally Mathias, M.D.; Aleina Milligan; her sister Kelly Milligan, the patient; Farhan Mirza, M.D., and Timothy Ainger, Ph.D. (University of Kentucky photo by Pete Comparoni)
By Hillary Smith
University of Kentucky

Aleina and Kelly Milligan of Columbia are more than sisters; they are truly best friends. For Kelly, her older sister has been a lifeline during the past two years.

“I was so excited when she decided she wanted to move down here because I thought, ‘This is awesome! I’m going to get to have my sister,’” Aleina said. “And then she got so sick.”

Kelly has dealt with seizures her entire life. She lived and worked in a sheltered employment program in Michigan and had worked as a custodian for 29 years. After experiencing some health issues while at work and after their mother passed away, Kelly decided to move in with her sister.

“She had no support system in Michigan, and it was just too much,” said Aleina.

But Aleina became concerned when she noticed a change in Kelly’s seizure patterns, so they came to see UK HealthCare’s Dr. Sally Mathias, an assistant professor of neurology who specializes in epilepsy.

“When I first saw her, I knew we needed to know more,” Mathias recalled. “She had never had some of the basic testing that is required for epilepsy, so we started off with that.”

The fact that Kelly’s seizure patterns had changed stood out to the epilepsy specialist, but that wasn’t all. “What is very rare is that her heart was actually stopping with every seizure — it is called ‘ictal bradycardia’,” said Mathias. “We noticed that on the Epilepsy Monitoring Unit. The longest her heart stopped while she was in our hospital was 20 seconds.”

To explore this further, they sent her home with a heart monitor for a few weeks. While at home, the heart monitor detected 30 seconds when Kelly’s heart had stopped.

“This was very serious and needed immediate attention,” said Mathias. “We directly admitted her to cardiology, and she got a pacemaker.”

Kelly was shocked to learn about what was happening with her body. This was all new for Aleina, but as they learned, she more says it did start to make sense.

“I was with her several times and experienced when she would just drop,” Aleina said. “There was one time I kept looking at her and thought ‘She is not breathing … surely not though, she must be breathing.’ After we found this out, I’m like, ‘OK, she wasn’t breathing.’ We are very fortunate that nothing has happened, and her heart continued to restart.”

After receiving her pacemaker, the next step for Kelly was epilepsy surgery, something she had never considered before meeting the doctors at UK HealthCare.

“It still baffles me that no one ever did basic testing for epilepsy on her, and that when I discussed epilepsy surgery with them, it was the first time they had heard of it,” said Mathias.

In August 2020, Dr. Farhan Mirza, assistant professor of neurosurgery and director of epilepsy surgery, successfully did surgery on Kelly’s brain. For the first time, she or her sister can remember, Kelly was seizure-free.

“We could go places and not have to go through the thought process of ‘What if?’” said Aleina. “For example, I had been thinking it would be wonderful to visit the beach and go swimming, but I was always afraid to get her in the water, because, what if she dropped?”

Mirza said, “Kelly's journey, like so many of our patients with refractory epilepsy, highlights two important things: No one should have to suffer from uncontrolled epilepsy for decades, and all patients who are resistant to anti-epileptic medications deserve to be evaluated for possible surgical options in a timely fashion. This can be done effectively only at highly specialized centers like UK where we offer advanced multi-disciplinary care for refractory epilepsy.”

The sisters were thrilled to have a greatly improved quality of life as Kelly celebrated her 50th birthday complete with a crown and a sash, less than two months after her epilepsy surgery.

“She was not limited anymore, and that is fantastic,” said Aleina.

Second chapter: Just weeks after celebrating her 50th birthday, two and a half months after her brain surgery, Kelly contracted Covid-19. She started showing symptoms about a week after Aleina came down with the virus. As Aleina recovered, Kelly’s symptoms worsened.

“She started telling me that she was having these strange neurological symptoms – tingling, burning, rushing feelings in her hands and feet, and continuous thoughts that she could not control,” said Aleina. “Kelly had never had any mental problems other than minor anxiety.”

After a few months of feeling like they could finally enjoy life together, Aleina was again reaching out to doctors with great concern for her sister.

“I read some articles about studies looking at the possibility that Covid can attack the weakest part of a person,” said Aleina. “I just assumed that would be her brain because she just had this major surgery.”

At that point, Covid-19 was still relatively new. Aleina says the doctors she spoke with did not know much about the virus other than to tell her that if Kelly’s breathing was okay, then she was okay.

“She continued to get worse … her brain, the tingling,” said Aleina. “It never presented in her lungs, but she just kept acting more strangely. She would say she was on fire and that she felt there was something evil after her.”

Kelly does not remember much of that time, and Aleina says that's a good thing. After about 10 days, Aleina took her to their local emergency department because she was afraid her sister was having another seizure. She wasn’t, though she had a fever and a low level of sodium.

The sisters continued to live like this for several more days and found themselves in the midst of the holiday season. Kelly continued to have a growing feeling that something was invading her body and mind. She then ended up back in the hospital with pancreatitis, which doctors attributed to her Covid-19 infection. Then just a few days after Christmas, Kelly tried to harm herself, and she was admitted to Eastern State Hospital.

“She was in full-blown psychosis,” said Aleina. “She was hallucinating and thought she was being told to harm herself or us.”

Her neurology doctors “were very concerned for her, but at that time there really were not any reports of COVID harming anybody mentally,” Aleina said. “They just didn’t know if it could be related.”

After three weeks at Eastern State, Kelly returned home on some medication that helped a little while, but quickly took a turn for the worse.

“She had gotten so bad … she was no longer my sister,” Aleina said. “It was horrible.”

Kelly was not eating. She would not communicate. Then, she began abusing her medications.

“I got ahold of Dr. Mirza and Dr. Mathias, and I was very honest with them and begged them to get her in for an appointment,” said Aleina. “I said, ‘I don’t know what is going on, but something is wrong, and she is going to die if we do not figure this out.’”

Drs. Mirza and Mathias, and neuropsychologist Timothy Ainger met with Kelly and decided that she couldn’t be sent back home. They knew right away that something was not right because she had undergone a neurocognitive evaluation as part of her pre-surgical workup, and the new results were much different.

“It is a very comprehensive evaluation of your cognitive abilities and how well your mind is functioning,” Ainger said. “She had gone from being talkative, engaged, and polite to being terrified, psychotic, and reserved.”

Her epilepsy doctors, Mirza and Mathias, had seen this surgery done successfully on so many patients and knew that this reaction was not typical. Mathias recalled, “We were naturally thinking, ‘Okay, what else is going on?’”

They said they felt good about Kelly’s surgery, but also knew that these issues occurred not long after it.

“She was doing great from a procedure perspective and didn’t have any issues,” said Mathias. “After surgery, some issues can develop. So that is what we were thinking … Maybe it wasn’t entirely because of the surgery … but I did have that in the back of my mind, because I can’t exclude that.”

The doctors also said operating on that area of Kelly’s brain wasn’t a likely cause for the type of psychiatric symptoms she was having. When Ainger looked through Kelly’s medical notes and history, he discovered the culprit.

“It then became very obvious,” Ainger said. “Right after she had just come out of the acute Covid illness, she had this rapid and sudden onset of symptomology. It was very similar to what the literature has been suggesting in the few cases that existed and very similar in one or two other patients that we had treated.”

They treated Kelly's case as some form of Covid-induced encephalitis, swelling of the brain, starting immunoglobulin therapy and changing one of her seizure medications.

“Within one week, my sister was back,” Aleina recalled. “She was still medicated with the anti-psychotic medication, but she was Kelly again.”

Since then, Aleina says they have been able to back Kelly off from 20 milligrams of her antipsychotic medication to one milligram.

“We completely believe we are going to be able to have her off that completely very soon,” Aleina said. “She is doing great. It has been a real journey.”

In the course of a year, Kelly has been on a roller coaster with her health: a dramatic brain surgery to rectify seizures, a bout of ovid-19, the development of psychosis, and then - thanks to intervention - back to normal and seizure-free. Through all those ups and downs, she and her sister are thankful for the team at UK.

“Because of the way this team works together, it was not six months, nine months, or even 12 months of working with other hospitals and dealing with referrals,” said Ainger.”We were able to just walk into each other’s offices, have meetings, and get this managed right away. That is not the kind of service people get from hospitals that don’t have multidisciplinary teams like this.”

In this case, the teamwork even went outside of the neurology department – it also included cardiology, considering Kelly’s prior heart issues and pacemaker.

“This one was different and a lot of cross-functional teamwork, but we do this for every patient,” said Mathias. “We come together to help our patients especially when they are going through such difficult times.”

Thanks to their teamwork and dedication, Kelly and Aleina are now finally getting to enjoy living in the same place.

“I’ve got her back and so now we can grow old together,” said Aleina. “I’m kind of already there, but we are so looking forward to it.”

“Kelly's story is truly one of years of anguish, a glimpse of seizure freedom, a calamitous decline, followed by a complete recovery,” said Mirza. “We are thrilled to see her faring so well and are honored to have been a part of Kelly and Aleina's inspirational journey.”

Thursday, February 20, 2020

House passes medical-marijuana bill, 65-30, after specifying illnesses for its use; Senate passage remains much in doubt

Photo illustration from MedicalMarijuana.com
Kentucky would be the 34th state to make marijuana legal for medicinal purposes, under a bill the state House passed Thursday by a vote of 65 to 30. The long-debated proposal has never gotten this far before, and it probably faces a tougher go in the Senate.

"The bill’s sponsor, Republican Jason Nemes of Louisville, and co-sponsor, Democrat John Sims of Flemingsburg, faced opposition from socially conservative lawmakers who are philosophically opposed to any legislation that could expand the legal use of marijuana and fear that a push to legalize recreational use of the drug would come next," reports Daniel Desrochers of the Lexington Herald-Leader.

“I hope it doesn’t, but you know it’s going to come,” said Rep. Stan Lee, R-Lexington, in a debate that lasted more than an hour. “If you lift the tent up a little and let the nose in, it's not going to stop.”

Nemes tried to address such concerns by having Dr. Jeffery Block, a University of Miami anesthesiologist, "testify in committee that the bill would contain enough regulations to prevent it from being abused," Desrochers points out. "The bill is intended to only allow edibles or pills — it prohibits smoking the marijuana — and forbids colorful packaging that could attract children. It does not allow people to grow marijuana in their homes, but does allow for sale of the marijuana flower, which is often used to smoke."

"The bill would allow doctors to prescribe marijuana for a list of conditions yet to be determined by a panel of 13 people — eight doctors, a pharmacist and four public advocates," Desrochers notes. One of the mostly minor amendments that the House added to the bill "ensured that the list of conditions would include chronic pain, epilepsy, multiple sclerosis and nausea or vomiting. All of those conditions have substantial or conclusive evidence that they are effectively treated by marijuana, according to Block."

Nemes told the House, “House Bill 136, if it is passed, would be the tightest medical marijuana bill in the country.” But Rep. Danny Bentley, R-Russell, a pharmacist, "peppered Nemes with questions about the bill and raised concerns that medical marijuana would not be regulated" by the U.S. Food and Drug Administration," Desrochers reports. "Supporters said the bill would help ease the suffering of many Kentuckians."

The bill would “bring relief to many citizens in this commonwealth,” said Rep. Patti Minter, D-Bowling Green.

"All but two Democratic members of the House voted for the bill, as did a slight majority of the Republican members present," notes Joe Sonka of the Louisville Courier Journal. The bill got more votes from Democrats (34) than from Republicans (31) in a House that has a strong Republican majority; that count could hurt its prospects in the even more strongly Republican Senate.

Senate President Robert Stivers has said more research is needed to prove marijuana's medicinal value, but more recently he said the bill has a "narrow path" to passage in the Senate. “It’s a balancing test of do the goods outweigh the bads,” he said. “And we just haven’t had anything done on that.”

"The renamed Department of Alcoholic Beverage and Cannabis Control would implement and regulate the new state program," Sonka notes. At least 25 medical-marijuana dispensaries would be set up around the state. Federal law prohibits pharmacies from selling marijuana, even in the states that have legalized it for medical use.

Read more here: https://www.kentucky.com/news/politics-government/article240477986.html?utm_source=pushly&intcid=pushly_484855#storylink=cpy

Read more here: https://www.kentucky.com/news/politics-government/article240477986.html?utm_source=pushly&intcid=pushly_484855#storylink=cpy

Thursday, June 14, 2018

McConnell gets hemp in Farm Bill, after argument with Iowa senator about inclusion of cannabinoids, including CBD oil

McConnell at the meeting (Associated Press photo by Jacquelyn Martin)
The Senate version of the Farm Bill contains Majority Leader Mitch McConnell's legalization of industrial hemp, but not without a dissent from another powerful senator who says it goes too far on a health-care issue.

The Senate Agriculture Committee passed the bill 20-1, and McConnell vowed to bring it to the Senate floor before July 4. The lone "no" vote came from Judiciary Committee Chair Charles Grassley of Iowa.

"Grassley’s objections to the farm bill appeared to be largely based on its language around industrial hemp," reports Marianne Goodland of Colorado Politics. Grassley "said he believed any language around industrial hemp ought not be included in the Farm Bill, but rather belongs in another bill that would go through his committee."

At issue is McConnell's language defining hemp, which includes cannabinoids, including CBD oil, which is used for a variety of medical conditions, especially in epileptic children. "However, the Food and Drug Administration has not approved those uses," Goodland notes. "Grassley argued that CBD oil is not an industrial hemp product."

The bill would let “any snake oil salesman” sell CBD without safety assurances, putting children at risk, Grassley argued. McConnell "said the bill incorporated suggestions made by the Judiciary Committee, the FDA and the Justice Department, including that the agriculture secretary could consult with the attorney general on state plans for hemp production. The bill, McConnell added, does not make hemp a legal commodity, and it also improves the integrity of the hemp program, to ensure that states and Indian tribes conduct proper oversight over their own hemp programs."

McConnell, making a rare appearance as a member of the committee, "said hemp could fill the market niche left when farmers in his state stopped growing tobacco," AgWeek reports, quoting him: “Younger farmers in my state are particularly interested in going in this direction, so I think it’s time for America.”

Friday, March 9, 2018

Medical marijuana bill shelved on 14-4 committee vote; legislature is fast running out of time to pass such a controversial bill

After three straight days of discussion, Kentucky lawmakers shelved a controversial but apparently popular bill to legalize medical marijuana, increasingly known as cannabis (its biological genus).

Jack Brammer of the Lexington Herald-Leader reports that supporters of the measure pledged to continue to their fight, with some in tears over the 14-4 vote by the House Judiciary Committee on March 7 to pass over the bill. With less than three weeks left in the legislative session, the vote probably ends debate on the bill for now.

Rep. John Sims
The bill's sponsor, Rep. John Sims, D-Flemingsburg, told Brammer that it's doubtful the proposal will be revisited this legislative session, but "anything is possible." The session must end by Sunday, April 15, and will be in recess for most of the preceding two weeks to allow reconsideration of any bills vetoed by the governor.

Sims's House Bill 166 would require a "medical order" from a health-care provider for distribution of marijuana through a state-regulated dispensary, with limits on how much cannabis a person could have at one time. Also, a city or a county would have a local-option vote to allow medical cannabis to be sold, and if the local government didn't act within two years, residents could petition for a vote. Participating governments would receive some revenue from an excise tax on the drug.

The bill would also prohibit public smoking of cannabis, and would require any person or business that wants to cultivate, distribute or sell it to have state-approved licenses.

The bill, which attracted a long list of bipartisan supporters, does not include a list of conditions that could be treated by cannabis. Jaimie Montavio of the nonprofit Kentuckians for Medicinal Marijuana gave the Louisville Courier Journal a list of conditions that would be in a substitute version of the bill, which Sims hasn't introduced. Some of those conditions include cancer, glaucoma, irritable bowel syndrome, multiple sclerosis, post-traumatic stress disorder and seizure disorders.

Rep. Jason Nemes
Rep. Jason Nemes, R-Louisville, who moved to pass over the bill after saying he supports the concept of medical marijiuana, told reporters that there’s still a chance it could be reconsidered this year if changes are made to it. For example, he said he especially didn't like the provision that would allow each medical patient to possess up to 12 mature cannabis plants, which “seems excessive.”

Secretary of State Alison Lundergan Grimes, a Democrat who formed a special panel last year headed by Sims to work on the legislation, told Brammer she hopes Nemes is serious about reaching a compromise. "Kentuckians overwhelmingly support medical cannabis," she said. "They are tired of waiting and will remember inaction at the ballot box in November."

The 2013 Kentucky Health Issues Poll found that 78 percent of Kentucky adults favored legalization of marijuana for medicinal purposes, and several legislators have said it is the issue that constituents contact them about most.

Grimes and Sgt. Dakota Meyer of Columbia, a Marine veteran who was awarded the Medal of Honor, wrote in a Herald-Leader op-ed that medical cannabis has helped several Kentuckians with varying health conditions, including Eric Pollack, who gets tremendous relief from marijuana for his PTSD and chronic pain suffered in combat. "Eric faces this impossible conundrum: be a criminal who is healthy at home or leave Kentucky for a place where medical cannabis is legal," they write.

So far, 29 states and the District of Columbia have authorized medical use of cannabis, including three neighboring states: Ohio, Illinois and West Virginia. Virginia and Tennessee are considering similar proposals this year.

The Louisville Metro Council overwhelmingly voted for a resolution urging lawmakers to pass a medical-marijuana law. Councilwoman Angela Leet told WDRB that of more than 600 responses to a survey, more than 90 percent of Louisvillians favor the idea. The Lexington-Fayette Urban County Government and the Bullitt County Fiscal Court have passed similar resolutions.

Proponents of the bill say medical marijuana would help people struggling with pain and other health conditions, noting that many people have already exhausted all other options and resources. Others say it would decrease use of opioids for pain.

Opponents, led by law-enforcement officers, say that medical cannabis would end up in the wrong hands, that it is often a gateway drug, that it sends the wrong message that marijuana is safe, and that we need more research on the long-term effects of the drug and whether it truly reduces opioid use.

Thursday, February 20, 2014

Legislature passes bill requiring schools to have trained employees to give insulin and epilepsy medication to students

A bill to require schools to have an employee on duty to administer insulin and epilepsy medication to students is on its way to Gov. Steve Beshear for final action.

House Bill 98, received final passage Thursday in the House, 96-2, after initial House passage and Senate amendments. The "no" votes were cast by Republican Reps. Ken Upchurch of Monticello and Ben Waide of Madisonville.

The bill would require that a licensed health worker, non-licensed health technician, or trained school employee be on duty at schools to administer or help with self-administration of insulin, other approved diabetes drugs, and seizure-rescue drugs approved by the federal government.

Written permission from a child’s parent or guardian, and instructions from the child’s health-care provider, would be required before any of the medications could be administered. The training requirements would go into effect July 15; the rest of the bill would take effect immediately.

The bill's sponsor, Democratic Rep. Bob Damron of Nicholasville, said it would make Kentucky the 34th state to adopt such legislation.

The bill would also allow children to perform their own blood-glucose checks and self-administer insulin at school with written request of parent or guardians and authorization by the child’s health provider.